Platinib’s medical insurance reimbursement ratio and usage and dosage instructions

Introduction: Pralsetinib by Blueprint Developed by Medicines, it is a potent and selective RET inhibitor that has been approved for the treatment of multiple indications, including adult patients with metastatic RET fusion-positive non-small cell lung cancer confirmed by FDA-approved testing methods, and adult patients with RET gene fusion-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have previously received platinum-containing chemotherapy. This article mainly talks about Platinib’s medical insurance reimbursement status, usage and dosage, purchase price, side effects, storage and use, genetic testing, etc.

Medical insurance reimbursement ratio

Platinib was approved for sale in China on March 23, 2021. By 2022, Platinib will be included in medical insurance, and the reimbursement category is Medical Insurance Category B. The proportion of medical insurance reimbursement will vary from region to region, but usually it is between 40% and 60%. When patients purchase platinib, they can enjoy a certain percentage of cost reimbursement, thus reducing their financial burden. When using medical insurance, patients should understand local medical insurance policies and reimbursement procedures in advance to ensure smooth reimbursement.

Usage and Dosage

The recommended dose of Platinib is 400 mg, taken orally once a day on an empty stomach (do not eat at least 2 hours before taking Platinib and at least 1 hour after taking Platinib). Treatment with Pratizumab can be continued until disease progression or intolerable toxicity occurs. If a dose of Platinib is missed, it should be taken as soon as possible that day and resume the regular daily dosing schedule the next day. If vomiting occurs after taking a dose, do not take additional doses, but continue with the next dose as planned.

Purchase Price

For the latest price information of Platinib, you can consult customer service staff.

Side Effects

There are also some possible side effects of using , including cough, fever, constipation, abdominal pain, diarrhea, fatigue, high blood pressure, musculoskeletal pain, etc. Platinib may also cause side effects on the blood system, liver and kidney function, and gastrointestinal tract. When using this drug, patients should follow their doctor's prescription recommendations and pay close attention to their body's reactions. If they experience any discomfort or suspected side effects, they should promptly inform their doctor.

Storage and use requirements

Platinib should be stored in a cool, dark, dry place, away from high temperature and moisture. During use, you should strictly follow the doctor's recommendations, and do not change the dosage and method at will.

The importance of genetic testing

Before using platinib, the presence of RET gene fusion positivity in the patient's tumor cells must be confirmed through a fully validated detection method. This is because platinib mainly targets tumor cells with RET gene mutations.

Platinib exerts anti-tumor effects by inhibiting the proliferation of tumor cells and promoting apoptosis. While using platinib, patients should closely monitor side effects and follow their doctor's recommendations to ensure the safety and effectiveness of treatment. A healthy lifestyle and a good diet can also help support a patient's recovery. If you have any questions or concerns, you should consult your doctor promptly.